Unknown

Dataset Information

0

Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".


ABSTRACT:

Purpose

Guidelines for variant interpretation incorporate variant hotspots in critical functional domains as evidence for pathogenicity (e.g., PM1 and PP2), but do not use "coldspots," that is, regions without essential functions that tolerate variation, as evidence a variant is benign. To improve variant classification we evaluated BRCA1 and BRCA2 missense variants reported in ClinVar to identify regions where pathogenic missenses are extremely infrequent, defined as coldspots.

Methods

We used Bayesian approaches to model variant classification in these regions.

Results

BRCA1 exon 11 (~60% of the coding sequence), and BRCA2 exons 10 and 11 (~65% of the coding sequence), are coldspots. Of 89 pathogenic (P) or likely pathogenic (LP) missense variants in BRCA1, none are in exon 11 (odds <0.01, 95% confidence interval [CI] 0.0-0.01). Of 34?P or LP missense variants in BRCA2, none are in exons 10-11 (odds <0.01, 95% CI 0.0-0.01). More than half of reported missense variants of uncertain significance (VUS) in BRCA1 and BRCA2 are in coldspots (3115/5301?=?58.8%). Reclassifying these 3115 VUS as likely benign would substantially improve variant classification.

Conclusion

In BRCA1 and BRCA2 coldspots, missense variants are very unlikely to be pathogenic. Classification schemes that incorporate coldspots can reduce the number of VUS and mitigate risks from reporting benign variation as VUS.

SUBMITTER: Dines JN 

PROVIDER: S-EPMC7200594 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".

Dines Jennifer N JN   Shirts Brian H BH   Slavin Thomas P TP   Walsh Tom T   King Mary-Claire MC   Fowler Douglas M DM   Pritchard Colin C CC  

Genetics in medicine : official journal of the American College of Medical Genetics 20200108 5


<h4>Purpose</h4>Guidelines for variant interpretation incorporate variant hotspots in critical functional domains as evidence for pathogenicity (e.g., PM1 and PP2), but do not use "coldspots," that is, regions without essential functions that tolerate variation, as evidence a variant is benign. To improve variant classification we evaluated BRCA1 and BRCA2 missense variants reported in ClinVar to identify regions where pathogenic missenses are extremely infrequent, defined as coldspots.<h4>Metho  ...[more]

Similar Datasets

| S-EPMC3826381 | biostudies-other
| S-EPMC3660339 | biostudies-literature
| S-EPMC7190647 | biostudies-literature
| S-EPMC3904950 | biostudies-literature
| S-EPMC6287763 | biostudies-literature
| S-EPMC8160182 | biostudies-literature
| S-EPMC3021973 | biostudies-literature
| S-EPMC2375115 | biostudies-literature
| S-EPMC9213547 | biostudies-literature
| S-EPMC6105370 | biostudies-literature